# NovaBridge Biosciences: Form SCHEDULE 13D, filed Aug 5, 2025

- Company: [NovaBridge Biosciences](/companies/nbp.md) (CIK 1778016)
- Form: SCHEDULE 13D
- Filed: 2025-08-05
- Accepted by EDGAR: Aug 5, 2025, 16:00 ET
- Period: not reported
- Accession: 0000950170-25-102964
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1778016/000095017025102964/xslSCHEDULE_13D_X01/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1778016/000095017025102964/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1778016/000095017025102964/xslSCHEDULE_13D_X01/primary_doc.xml

Filed Aug 5, 2025.
Source: SEC EDGAR, the filing index for accession 0000950170-25-102964. Last ingested by Listed: Oct 28, 2026, 07:01 ET. No prices; not investment advice.